NIH-NIAID-Conferences-20558a

U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) 21st International Conference on Emerging Infectious Diseases in the Pacific Rim

ACUTE RESPIRATORY INFECTIONS PANEL MEETING

  

 

Thursday, 28 February 2019

 

8:20-8:30

 

Opening remarks – ARI Panel Chairs

Yohei Doi, Fujita Health University and University of Pittsburgh School of Medicine

Jorge Vidal, Emory University

 

 

8:30-9:00

 

 

9:00-9:30

 

 

9:30-10:00

 

 

10:00-10:30

 

 

10:30-10:45

 

10:45-11:15

 

 

11:15-11:45

 

 

11:45-12:15

 

 

12:15-13:30

 

 

13:30-14:00

 

 

14:00-14:30

Session – Epidemiology & Antimicrobial Resistance

 

What we learned from five years enhanced surveillance of invasive pneumococcal disease

Kazunori Oishi, National Institute of Infectious Diseases

 

Effects of antibiotic stewardship program at a tertiary hospital in Vietnam

Le Thi Anh Thu, Cho Ray Hospital

 

Trends in invasive Haemophilus influenzae (Hflu) infection after the introduction of Hflu type b conjugate vaccine, and clinical characteristics of Hflu isolates, in Japan Mayumi Kubota, National Institute of Infectious Diseases

 

High and increasing levels of beta-lactam and cephalosporin resistance in Streptococcus pneumoniae among children in rural Vietnam, cross sectional studies 1999 to 2014 Mattias Larsson, Karolinska Institutet

 

Break

 

Nationwide survey of pediatric empyema in Japan

Naruhiko Ishiwada, Chiba University

 

Novel Diagnostics to Improve Antimicrobial Use for Acute Respiratory Infections, Sri Lanka

Gayani Tillekeratne, Duke University

 

Current topics in Mycoplasma pneumoniae infections among Japanese children

Tsutomu Yamazaki, Wakaba Children’s Clinic Lunch

Session – Microbiology, Immunology, and Vaccines

 

Molecular epidemiological analysis of antimicrobial drug-resistant

Streptococcus penumoniae and Haemophilus influenzae isolated in Sapporo, in Japan

Toyotaka Sato, Sapporo Medical University

 

Pneumococcal conjugate vaccine and pneumococcal carriage studies in the Asia-Pacific region

Fiona Russell, Murdoch Children’s Research Institute


14:30-15:00

Calculating the critical community size of S. pneumoniae transmission

 

Ben Althouse, Institute for Disease Modeling

15:00-15:30

Regulation of B cell responses to pneumococcal polysaccharides

 

Karen Haas, Wake Forest School of Medicine

15:30-15:45

Break

 

Session – Genotyping, Drug Discovery, and Antimicrobial Resistance

15:45-16:15

Evaluation of genotyping methods of Mycoplasma pneumoniae

 

Tsuyoshi Kenri, National Institute of Infectious Diseases

16:15-16:45

Fluoroquinolone non-susceptible Streptococcus pyogenes in Japan

 

Kenji Gotoh, Kurume University

16:45-17:15

A systematic whole genome-based approach to discover novel druggable targets in the

 

respiratory pathogen Pseudomonas aeruginosa

 

Thulasi Warrier, Broad Institute

  Friday, 01 March 2019                                                                                                                           

 

Session – Mechanisms of Antimicrobial Resistance

8:30-9:00

Mutations-associated, and transposon-mediated, antibiotic resistance is disseminated via transformation among Streptococcus pneumoniae strains

 

Jorge Vidal, Emory University

9:00-9:30

Molecular epidemiological analysis of antimicrobial drug-resistant Streptococcus pneumoniae and Haemophilus influenzae isolated in Sapporo, in Japan

 

Masato Suzuki, National Institute of Infectious Diseases

9:30-9:45

Break

9:45-10:15

Quiet Threat

Motoyuki Sugai, National Institute of Infectious Diseases

10:15-10:45

Prospective multicentre surveillance of clinically isolated filamentous fungi in the Kyoto and Shiga regions of Japan.

 

Miki Nagao, Kyoto University

10:45-11:15

Unraveling colistin resistance of Acinetobacter baumannii

Yohei Doi, Fujita Health University

11:15-11:20

Closing remarks – ARI Panel Chairs


Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top